267 results on '"Aberle, Judith H."'
Search Results
2. Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
3. Symptoms associated with a COVID-19 infection among a non-hospitalized cohort in Vienna
4. Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial
5. The systemic renin-angiotensin system in COVID-19
6. Torque teno viruses exhaust and imprint the human immune system via the HLA-E/NKG2A axis.
7. Diagnostic potential of blood plasma longitudinal viscosity measured using Brillouin light scattering.
8. Neutralization of SARS‐CoV‐2 Omicron XBB.1.5 and JN.1 variants after COVID‐19 booster‐vaccination and infection.
9. CD4 T cell responses to flaviviruses
10. Mimicking Live Flavivirus Immunization with a Noninfectious RNA Vaccine
11. Effect of previous heterologous flavivirus vaccinations on human antibody responses in tick‐borne encephalitis and dengue virus infections
12. Longitudinal viscosity of blood plasma for rapid COVID-19 prognostics
13. Humoral immune response to tick-borne encephalitis vaccination in allogeneic blood and marrow graft recipients
14. Author Correction: Humoral immune response to tick-borne encephalitis vaccination in allogeneic blood and marrow graft recipients
15. Structural Framework for Analysis of CD4+ T-Cell Epitope Dominance in Viral Fusion Proteins
16. The Chemokine CXCL-10 Is a Marker of Infection Stage in Individuals With DNAemia Due to Parvovirus B19
17. Respiratory syncytial virus surge in 2022 caused by lineages already present before the COVID‐19 pandemic
18. TBE in Austria
19. Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
20. Approaches for monitoring of non virus-specific and virus-specific T-cell response in solid organ transplantation and their clinical applications
21. The respiratory syncytial virus surge in Austria, 2022, was caused by lineages present before the COVID-19 pandemic
22. Immune response after mRNA COVID-19 vaccination in heart transplant recipients: long-term follow-up and evaluation of a third vaccination
23. A diagnostic score for the prediction of spontaneous resolution of acute hepatitis C virus infection
24. Intracranial hemorrhage and other symptoms in infants associated with human parechovirus in Vienna, Austria
25. Serum Level of IP-10 Increases Predictive Value of IL28B Polymorphisms for Spontaneous Clearance of Acute HCV Infection
26. Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls
27. Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study
28. Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections
29. Immune Response after mRNA COVID-19 Vaccination in Lung Transplant Recipients: A 6-Month Follow-Up
30. The Systemic Renin-Angiotensin System in COVID-19
31. Dynamic Coinfection with Multiple Viral Subtypes in Acute Hepatitis C
32. CD4⁺ T Cell Responses in Patients with Chronic Hepatitis C Undergoing Peginterferon/Ribavirin Therapy Correlate with Faster, but Not Sustained, Viral Clearance
33. Heterogeneous SARS-CoV-2-Neutralizing Activities After Infection and Vaccination
34. Long-Lived Immunity in SARS-CoV-2-Recovered Children and Its Neutralizing Capacity Against Omicron
35. The First Case of Usutu Virus Neuroinvasive Disease in Austria, 2021
36. Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd Vaccination
37. Immune response after mRNA COVID-19 vaccination in heart transplant recipients: long-term follow-up and evaluation of a third vaccination.
38. Adenovirus DNA in Serum of Children Hospitalized Due to an Acute Respiratory Adenovirus Infection
39. B Cell Depletion and SARS‐CoV ‐2 Vaccine Responses in Neuroimmunologic Patients
40. Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients
41. Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial
42. SARS-CoV-2 neutralising antibody response to bivalent booster after omicron infection
43. Acute infection with a single hepatitis C virus strain in dialysis patients: Analysis of adaptive immune response and viral variability
44. Mechanistic insights into the impairment of memory B cells and antibody production in the elderly
45. Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomized controlled trial
46. Tick-Borne Encephalitis Specific Lymphocyte Response after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Humoral Immunity after Vaccination
47. SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity
48. Quantitative real time PCR detection of Varicella-zoster virus DNA in cerebrospinal fluid in patients with neurological disease
49. ACE2 Elevation in Severe COVID-19
50. First Case of Usutu Virus Neuroinvasive Disease in Austria, 2021.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.